Skip to content

Research on ultra-slow and high-intensity resistance training for chronic diseases in the background of sports-medical integration

Research on ultra-slow and high-intensity resistance training for chronic diseases in the background of sports-medical integration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080540
Enrollment
Unknown
Registered
2024-01-31
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic disease

Interventions

Slow-speed and high-strength resistance training group:Give ultra-slow and high-intensity resistance training, focusing on "muscle failure for each movement". Through slow and smooth centrifugal and c
control group:No exercise intervention was performed.

Sponsors

Yancheng First People's Hospital(The First Affiliated Hospital of Jiangsu Medical Vocational College)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Age range: 18-60.(2) Informed, consent and sign the informed consent form, and voluntarily join the investigator.(3) Those who have a clear consciousness and can correctly express their own opinions.(4) People with non-infectious chronic diseases such as diabetes and hypertension.

Exclusion criteria

Exclusion criteria: (1) people with a history of mental illness or severe cognitive function or language impairment.(2) Severe physical function impairment.

Design outcomes

Primary

MeasureTime frame
6-minute walk test;blood pressure ;blood fat ;blood sugar ;Number of squats in 1 minute;Treadmill test;

Countries

China

Contacts

Public ContactDong xinchun

Yancheng First People's Hospital(The First Affiliated Hospital of Jiangsu Medical Vocational College)

40041@163.com+86 134 0001 2257

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026